We also demonstrate that RhoG mediates signaling that is stimulated by cMet and EGFR, two receptors that are deregulated in glioblastoma tumors and that RhoG is overexpressed in human glioblastoma tumor tissue versus non-neoplastic brain. Here, MET is linked to neoplasm.